ID

35012

Beschreibung

Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02364726

Link

https://clinicaltrials.gov/show/NCT02364726

Stichworte

Versionen (1)
  1. 08.02.19 08.02.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

8. Februar 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT02364726

Englisch

Eligibility Breast Cancer NCT02364726

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
screening phase:
Beschreibung

Screening Phase

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0220908
UMLS CUI [1,2]
C1710475
age 21 or older.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
histologically proven stage i-iii carcinoma of the breast.
Beschreibung

Breast Carcinoma TNM Breast tumor staging

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0474926
plan to receive adjuvant or neoadjuvant chemotherapy that includes weekly paclitaxel.
Beschreibung

Adjuvant Chemotherapy Planned | Chemotherapy Neoadjuvant Planned | Paclitaxel Weekly

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0085533
UMLS CUI [1,2]
C1301732
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0600558
UMLS CUI [2,3]
C1301732
UMLS CUI [3,1]
C0144576
UMLS CUI [3,2]
C0332174
eastern cooperative oncology group performance status 0-2 (see appendix b).
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
the patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
proficiency in english with the ability to speak and read english.
Beschreibung

Able to speak English Language | Able to read English Language

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0564215
UMLS CUI [1,2]
C0376245
UMLS CUI [2,1]
C0586740
UMLS CUI [2,2]
C0376245
intervention phase:
Beschreibung

Intervention Phase

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0184661
UMLS CUI [1,2]
C1710475
age 21 or older.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
histologically proven stage i-iii carcinoma of the breast.
Beschreibung

Breast Carcinoma TNM Breast tumor staging

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0474926
receiving adjuvant or neoadjuvant chemotherapy that includes a taxane.
Beschreibung

Chemotherapy, Adjuvant | Chemotherapy Neoadjuvant | taxane

Datentyp

boolean

Alias
UMLS CUI [1]
C0085533
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0600558
UMLS CUI [3]
C0215136
eastern cooperative oncology group performance status 0-2
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
the patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
proficiency in english with the ability to speak and read english
Beschreibung

Able to speak English Language | Able to read English Language

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0564215
UMLS CUI [1,2]
C0376245
UMLS CUI [2,1]
C0586740
UMLS CUI [2,2]
C0376245
while on neurotoxic chemotherapy, has developed nci-ctc grade 2 cipn
Beschreibung

Chemotherapy | Neurotoxicity CTCAE Grades

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2,1]
C0235032
UMLS CUI [2,2]
C1516728
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
known metastatic (stage iv) breast cancer involvement.
Beschreibung

Secondary malignant neoplasm of female breast Involvement

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0346993
UMLS CUI [1,2]
C1314939
pre-existing peripheral neuropathy before chemotherapy is initiated.
Beschreibung

Peripheral Neuropathy Pre-existing

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C2347662
currently taking anti-neuropathy medication such as gabapentin, pregabalin, duloxetine, or glutamine.
Beschreibung

Pharmaceutical Preparations Against Neuropathy | gabapentin | pregabalin | duloxetine | Glutamine

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0521124
UMLS CUI [1,3]
C0442874
UMLS CUI [2]
C0060926
UMLS CUI [3]
C0657912
UMLS CUI [4]
C0245561
UMLS CUI [5]
C0017797
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT02364726

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Screening Phase
Item
screening phase:
boolean
C0220908 (UMLS CUI [1,1])
C1710475 (UMLS CUI [1,2])
Age
Item
age 21 or older.
boolean
C0001779 (UMLS CUI [1])
Breast Carcinoma TNM Breast tumor staging
Item
histologically proven stage i-iii carcinoma of the breast.
boolean
C0678222 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
Adjuvant Chemotherapy Planned | Chemotherapy Neoadjuvant Planned | Paclitaxel Weekly
Item
plan to receive adjuvant or neoadjuvant chemotherapy that includes weekly paclitaxel.
boolean
C0085533 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0600558 (UMLS CUI [2,2])
C1301732 (UMLS CUI [2,3])
C0144576 (UMLS CUI [3,1])
C0332174 (UMLS CUI [3,2])
ECOG performance status
Item
eastern cooperative oncology group performance status 0-2 (see appendix b).
boolean
C1520224 (UMLS CUI [1])
Informed Consent
Item
the patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.
boolean
C0021430 (UMLS CUI [1])
Able to speak English Language | Able to read English Language
Item
proficiency in english with the ability to speak and read english.
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0586740 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
Intervention Phase
Item
intervention phase:
boolean
C0184661 (UMLS CUI [1,1])
C1710475 (UMLS CUI [1,2])
Age
Item
age 21 or older.
boolean
C0001779 (UMLS CUI [1])
Breast Carcinoma TNM Breast tumor staging
Item
histologically proven stage i-iii carcinoma of the breast.
boolean
C0678222 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
Chemotherapy, Adjuvant | Chemotherapy Neoadjuvant | taxane
Item
receiving adjuvant or neoadjuvant chemotherapy that includes a taxane.
boolean
C0085533 (UMLS CUI [1])
C0392920 (UMLS CUI [2,1])
C0600558 (UMLS CUI [2,2])
C0215136 (UMLS CUI [3])
ECOG performance status
Item
eastern cooperative oncology group performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Informed Consent
Item
the patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.
boolean
C0021430 (UMLS CUI [1])
Able to speak English Language | Able to read English Language
Item
proficiency in english with the ability to speak and read english
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0586740 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
Chemotherapy | Neurotoxicity CTCAE Grades
Item
while on neurotoxic chemotherapy, has developed nci-ctc grade 2 cipn
boolean
C0392920 (UMLS CUI [1])
C0235032 (UMLS CUI [2,1])
C1516728 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Secondary malignant neoplasm of female breast Involvement
Item
known metastatic (stage iv) breast cancer involvement.
boolean
C0346993 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
Peripheral Neuropathy Pre-existing
Item
pre-existing peripheral neuropathy before chemotherapy is initiated.
boolean
C0031117 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
Pharmaceutical Preparations Against Neuropathy | gabapentin | pregabalin | duloxetine | Glutamine
Item
currently taking anti-neuropathy medication such as gabapentin, pregabalin, duloxetine, or glutamine.
boolean
C0013227 (UMLS CUI [1,1])
C0521124 (UMLS CUI [1,2])
C0442874 (UMLS CUI [1,3])
C0060926 (UMLS CUI [2])
C0657912 (UMLS CUI [3])
C0245561 (UMLS CUI [4])
C0017797 (UMLS CUI [5])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video